Will GLP-1RAs ultimately succeed in the marketplace for obesity treatments, where other weight loss drugs have failed? In the first of a two-part blog series, we explore their use as a treatment of Type 2 diabetes & obesity.
Augmented reality, VR & other aspects of the metaverse are beginning to impact healthcare, from disability & elder care to hospital triage, surgical training, clinical trial monitoring, mental health & physical therapy.
What will the recent accelerated approval of anti-amyloid lecanemab mean for Alzheimers patients, and will it overcome stringent CMS reimbursement policies?